ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
University of Arizona at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
University of Arizona brings 5 presentations from 3 research groups to ASHG 2026 in Montréal. Its program centres on rare disease, population and clinical genetics, and therapeutic applications. The Karnes Lab brings All of Us pharmacogenomic analyses and platelet-factor-4 findings across diverse populations, the Kruer Lab brings work expanding the FBXO31-related neurodevelopmental disorder spectrum, and the Romanoski Lab brings single-cell studies of cardiovascular risk in endothelial cells.
| Organization | ASHG 2026 Attendance |
|---|---|
University of Arizona Tucson, Arizona | 3 PhD Students · 1 PI |
Karnes Labkarnes.lab.arizona.edu Uses All of Us, electronic health records, GWAS and single cell-RNA-TCR-CITE-seq to study cardiovascular and immune pharmacogenomics. Aims to improve genotype-guided prescribing for anticoagulant safety.
| Talk Wed Oct 21 2:23 pm Phenome-wide association of pharmacogenomic metabolizer and functional status in the All of Us research program Phenome-wide associationPharmacogenomicsElectronic health recordsPopulation genetics Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Phenome-wide association of pharmacogenomic metabolizer and functional status in the All of Us research programElectronic health recordsPharmacogenomicsPhenome-wide associationPopulation genetics |
Kruer Labkruerlab.org Uses whole-exome trio studies and validates genes in Saccharomyces, Drosophila and patient-derived iPSC neurons. Targets genetic causes of cerebral palsy and pediatric movement disorders.
| Poster Wed Oct 21 2:30 pm Expanding the phenotypic spectrum of the recurrent de novo FBXO31 p.Asp334Asn variant: Evidence for a novel neurodevelopmental disorder (Kruer syndrome) Candidate geneCharacterization of syndromesClinical geneticsDevelopment |
Romanoski Labsites.arizona.edu/romanoski-lab/home/people Studies endothelial-cell gene regulation using single-cell RNA sequencing. Targets atherosclerosis, hypertension and GWAS loci.
| Talk Thu Oct 22 9:15 am Single-cell profiling of genetic risk for cardiovascular disease in endothelial cell ‘populations-in-a-dish’ under athero-prone and athero-protective shear stress Cardiovascular systemExpression quantitative trait lociSingle-cellComplex diseases |
Find decision makers at University of Arizona
Tell us what you sell and we’ll find the people at University of Arizona most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction